Letter: biologics treatment in Crohn’s disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? Authors’ reply.

Letter: biologics treatment in Crohn’s disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? Authors’ reply. Aliment Pharmacol Ther. 2018 Jan;47(1):147-148 Authors: Eberhardson M, Söderling JK, Olén O PMID: 29226402 [PubMed – in process] PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/29226402?dopt=Abstract

Read More

Letter: biologics treatment in Crohn’s disease and risk of bowel resection-what about the patients who stop anti-TNF therapy?

Letter: biologics treatment in Crohn’s disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? Aliment Pharmacol Ther. 2018 Jan;47(1):146-147 Authors: Ribaldone DG, Saracco G, Astegiano M, Pellicano R PMID: 29226397 [PubMed – in process] PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/29226397?dopt=Abstract

Read More

Risk factors for postoperative recurrence after primary bowel resection in patients with Crohn’s disease.

Related Articles Risk factors for postoperative recurrence after primary bowel resection in patients with Crohn’s disease. World J Gastroenterol. 2017 Oct 14;23(38):7016-7024 Authors: Yang KM, Yu CS, Lee JL, Kim CW, Yoon YS, Park IJ, Lim SB, Park SH, Ye BD, Yang SK, Kim JC Abstract AIM: To evaluate the risk factors for postoperative recurrence after primary bowel resection in a cohort of Korean Crohn’s disease (CD) patients. METHODS: This study included 260 patients with no history of previous bowel surgery who underwent primary surgery for CD between January 2000…

Read More

Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery.

Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol. 2017 Sep 21;23(35):6474-6481 Authors: Lee DW, Koo JS, Choe JW, Suh SJ, Kim SY, Hyun JJ, Jung SW, Jung YK, Yim HJ, Lee SW Abstract AIM: To investigate the factors affecting diagnostic delay and outcomes of diagnostic delay in inflammatory bowel disease (IBD). METHODS: We retrospectively studied 165 patients with Crohn’s disease (CD) and 130 patients with ulcerative colitis (UC) who were diagnosed and had follow up durations > 6 mo at Korea University Ansan…

Read More

Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn’s disease.

Related Articles Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn’s disease. Aliment Pharmacol Ther. 2017 Oct 20;: Authors: Lang BM, Biedermann L, van Haaften WT, de Vallière C, Schuurmans M, Begré S, Zeitz J, Scharl M, Turina M, Greuter T, Schreiner P, Heinrich H, Kuntzen T, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B, Swiss IBD Cohort Study Group Abstract BACKGROUND: Smoking is a strong environmental factor leading to adverse outcomes in Crohn’s disease, but a more benign course in ulcerative colitis. Several…

Read More

Development of Clinical Prediction Models for Surgery and Complications in Crohn’s Disease.

Development of Clinical Prediction Models for Surgery and Complications in Crohn’s Disease. J Crohns Colitis. 2017 Sep 19;: Authors: Guizzetti L, Zou G, Khanna R, Dulai PS, Sandborn WJ, Jairath V, Feagan BG Abstract Background and Aims: Crohn’s disease-related complications account for a substantial proportion of inflammatory bowel disease-associated healthcare expenditure. Identifying patients at risk for complications may allow for targeted use of early therapeutic interventions to off-set this natural course. We aimed to develop risk prediction models for Crohn’s disease-related surgery and complications. Methods: Using data from the Randomized…

Read More

Letter: the outcome of ulcerative colitis patients undergoing pouch surgery may be determined by pre-surgical factors. Authors’ reply.

Letter: the outcome of ulcerative colitis patients undergoing pouch surgery may be determined by pre-surgical factors. Authors’ reply. Aliment Pharmacol Ther. 2017 Nov;46(9):902-903 Authors: Yanai H, Ben-Shachar S, Mlynarsky L, Godny L, Leshno M, Tulchinsky H, Dotan I PMID: 29023887 [PubMed – in process] PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/29023887?dopt=Abstract

Read More

Risk Stratification for Surgery in Stricturing Ileal Crohn’s Disease: The BACARDI Risk Model.

Risk Stratification for Surgery in Stricturing Ileal Crohn’s Disease: The BACARDI Risk Model. J Crohns Colitis. 2017 Aug 03;: Authors: Bossuyt P, Debeuckelaere C, Ferrante M, de Buck van Overstraeten A, Vanbeckevoort D, Billiet T, Wolthuis A, Cleynen I, Van Assche G, D’Hoore A, Vermeire S Abstract Background and Aim: Transmural inflammation in Crohn’s disease [CD] leads to stricturing or penetrating complications. Factors impacting on the need and timing of surgery in ileal stricturing CD [IS-CD] are understudied. Our aim was to identify risk factors in IS-CD associated with the…

Read More
<< Go Back